Digital Based Practice Examples in Heart Failure Management

Abdulla ARSLANa, Hakan ALTAYa

aBaşkent Üniversitesi İstanbul Sağlık Uygulama ve Araştırma Merkezi, Kardiyoloji, Kliniği istanbul, TÜRKİYE

ABSTRACT
Heart failure remains to be a serious morbidity and mortality problem despite a lot of recent advances in diagnosis, follow-up and treatment. Since it’s a complex,chronic, progressive and more importantly very prevalent clinical syndrome, its diagnosis and follow-up is challenging. Inadequacy in the diagnosis and follow-up of HF prevents timely and effective treatment as well. Due to this requirement, digital technology which proves to be useful in many fields has started to find place in cardiology and especially in HF field. Thus, studies investigating the effect of digital technology on the course of HF has been released one after another. Digital technology, if used widespread on the diagnosis and and follow-up of HF seems to be a good candidate to improve the prognosis of HF and also mitigate the burden of HF on the healthcare system in the future.
Keywords: Heart failure; diagnosis; aftercare

Referanslar

  1. Stewart S, Macıntyre K, Hole Dj, Capewell S, McMurray jjV. More malignant than cancer? Five-year survival following a first admission for heart failure. Eur j Heart Fail. 2001;3:315- 22 [Crossref]  [PubMed]
  2. McMurray jj, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al; ESC Committee for Practice Guidelines. ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur j Heart Fail. 2012;14(8): 803-69 [Crossref]  [PubMed]
  3. Liu L, Eisen Hj. Epidemiology of heart failure and scope of the problem. Cardiol Clin. 2014;32(1):1-8 [Crossref]  [PubMed]
  4. Ulağlı S. İletişim Araçları. Motto Yayınları: 2020. p.162.
  5. International Telecommunication Union, Measuring the ınformation Society. Geneva, Switzerland; ınternational Telecommunication Union, Place des Nations, CH-1211;2013
  6. Hanson VL. Technology skill and age: what will be the same 20 years from now? Univ Access ınf Soc. 2011;10(4):443-52 [Crossref]
  7. Lind L, Karlsson D, Fridlund B. Patients' use of digital pens for pain assessment in advanced palliative home healthcare. ınt j Med ınform. 2008;77(2):129-36 [Crossref]  [PubMed]
  8. Leili Lind, PhD, RN, Gunnar Carlgren, MD, Daniel Karlsson, PhD. old-and With Severe Heart Failure Telemonitoring by Using Digital Pen Technology in Specialized Homecare: System Description, ımplementation, and Early Results. Feature Article. Comput ınform Nurs. 2016;34(8):360-8. [Crossref]  [PubMed]
  9. Hahnen C, Freeman CG, Haldar N, Hamati jN, Bard DM, Murali V, et al. Accuracy of Vital Signs Measurements by a Smartwatch and a Portable Health Device: Validation Study. jMıR Mhealth Uhealth. 2020;8(2): e16811. [Crossref]  [PubMed]  [PMC]
  10. Ambrosy AP, Fonarow GC, Butler j, Chioncel o, Greene Sj, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure:lessons learned from hospitalized heart failure registries. j Am Coll Cardiol. 2014;63(12):1123- 33. [Crossref]  [PubMed]
  11. Butler j, Braunwald E, Gheorghiade M. Recognizing worsening chronic heart failure as an entity and an end point in clinical trials.jAMA. 2014;312(8):789-90. [Crossref]  [PubMed]
  12. O'Connor CM(1), Miller AB, Blair jE, Konstam MA, Wedge P, Bahit MC,et al; Efficacy of Vasopressin Antagonism in heart Failure outcome Study with Tolvaptan (EVEREST) investigators Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results fromEfficacy of Vasopressin Antagonism in Heart Failure outcome Study with Tolvaptan (EVEREST) program.Am Heart j. 2010;159(5):841-849. e1. [Crossref]  [PubMed]
  13. Stehlik j, Schmalfuss C, Bozkurt B, NativiNicolau j, Wohlfahrt P, Wegerich Set al. Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LıNK-HF Multicenter Study. Circ Heart Fail. 2020;13(3): e006513. [Crossref]  [PubMed]
  14. Aaronson KD, Cowger j. Heart failure prognostic models: why bother? Circulation Heart failure. 2012;5:6-9 [Crossref]  [PubMed]  [PMC]
  15. Canepa M, Fonseca C, Chioncel o, Laroche C, Crespo-Leiro MG, Coats AjS, et al. ESC HF Long Term Registry ınvestigators. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry.jACC Heart Fail. 2018;6(6):452-62. [Crossref]  [PubMed]
  16. Elliott P, AnderssonB, Arbustini E, Bilinska Z, Cecchi F, Charron P et al. Classification of the cardiomyopathies: a position statement from theEuropean Society of Cardiology working group on myocardial and pericardialdiseases. EurHeart j. 2008;29:270-6 [Crossref]  [PubMed]
  17. Sammani A, jansen M, Linschoten M, Bagheri A, de jonge N,Kirkels H, et al. UNRAVEL: big data analytics research data platform to improve care of patients with cardiomyopathies using routine electronic health records and standardised biobanking.Neth Heart j. 2019;27(9):426-34. [Crossref]  [PubMed]  [PMC]
  18. Tajrishi FZ, Chitsazan M, Chitsazan M, Shojaei F, Gunnam V, Chi G. Smartwatch for the Detection of Atrial Fibrillation. Crit Pathw Cardiol. 2019;18(4):176-84. [Crossref]  [PubMed]
  19. Tajrishi FZ, Chitsazan M, Chitsazan M, Shojaei F, Gunnam V, Chi G. Smartwatch for the Detection of Atrial Fibrillation. Crit Pathw Cardiol. 2019;18(4):176-84. [Crossref]  [PubMed]
  20. Ponikowski, P. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. j. Heart Fail. 2016;18:891- 975 [Crossref]  [PubMed]
  21. Ledley, R. S. & Lusted, L. B. Reasoning foundations of medical diagnosis; symbolic logic, probability, and value theory aid our understanding of how physicians reason. Science 1959;130:9-21. [Crossref]  [PubMed]
  22. Choi Dj, Park jj, Ali T, Lee S. Artificial intelligence for the diagnosis of heart failure.NPj Digit Med. 2020;3:54. [Crossref]  [PubMed]  [PMC]